Purpose The study aimed to provide a comprehensive bibliometric overview of the current
scientific publications on fibroblast activation protein inhibitor (FAPI) positron emission …

Purpose: Recent studies suggest that 68 Ga-FAPI PET/CT demonstrated superiority over 18
F-FDG PET/CT in the evaluation of various cancer types, especially in gastric cancer (GC) …

Purpose Positron emission tomography/computed tomography (PET/CT) based on fibroblast
activation protein inhibitors (FAPI) has shown complementary values to 2-[18F]-fluoro-2 …

Purpose We aimed to investigate the role of [68 Ga] Ga-FAPI-04 PET/CT and uptake
patterns of primary and metastatic lesions in patients with renal cell carcinoma (RCC) …

Abstract Purpose The radiopharmaceutical [18F] AlF-NOTA-FAPI-04 presents a promising
alternative to 68 Ga-FAPI owing to its relatively longer half-life. This study aimed to evaluate …

Please see the Editorial Comment by Sree Harsha Tirumani discussing this article.
BACKGROUND. FDG PET/CT has limited diagnostic performance in the detection of …

Overexpression of fibroblast activation protein (FAP) in cancer-associated fibroblasts in a
wide variety of tumors enables a highly selective targeting strategy using FAP inhibitors …

Simple Summary The fibroblast activation protein (FAP) is highly expressed on cancer-
associated fibroblasts in many tumors. Radiolabeled FAP inhibitors (FAPIs) have been …

Aim In this study, we aimed to compare the diagnostic accuracy of 18 F− fluorodeoxyglucose
(18 F-FDG) and Gallium-68 labeled fibroblast activator protein inhibitor (68 Ga-FAPI)-04 …

Purpose The purpose of this study is to compare the application value of 68Ga-FAPI and
18F-FDG PET/CT in primary and metastatic lesions of abdominal and pelvic malignancies …